Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cerus Corporation stock logo
CERS
Cerus
$2.58
-1.3%
$1.99
$1.15
$3.15
$514.75M1.621.87 million shs792,502 shs
Neogen Corporation stock logo
NEOG
Neogen
$9.02
-2.5%
$9.58
$4.53
$11.43
$1.96B1.843.13 million shs308,637 shs
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
$10.93
+1.4%
$16.15
$10.21
$38.99
$743.99M0.751.81 million shs339,385 shs
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$26.49
-2.9%
$21.56
$15.59
$30.81
$1.32B1.21.38 million shs127,557 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cerus Corporation stock logo
CERS
Cerus
+0.77%+28.57%+41.85%+18.64%+100.77%
Neogen Corporation stock logo
NEOG
Neogen
+0.76%-1.60%-7.31%-14.35%+55.99%
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
-1.73%-12.44%-28.10%-62.99%-58.34%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
-1.69%+3.49%+29.35%+55.18%+40.33%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cerus Corporation stock logo
CERS
Cerus
$2.58
-1.3%
$1.99
$1.15
$3.15
$514.75M1.621.87 million shs792,502 shs
Neogen Corporation stock logo
NEOG
Neogen
$9.02
-2.5%
$9.58
$4.53
$11.43
$1.96B1.843.13 million shs308,637 shs
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
$10.93
+1.4%
$16.15
$10.21
$38.99
$743.99M0.751.81 million shs339,385 shs
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$26.49
-2.9%
$21.56
$15.59
$30.81
$1.32B1.21.38 million shs127,557 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cerus Corporation stock logo
CERS
Cerus
+0.77%+28.57%+41.85%+18.64%+100.77%
Neogen Corporation stock logo
NEOG
Neogen
+0.76%-1.60%-7.31%-14.35%+55.99%
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
-1.73%-12.44%-28.10%-62.99%-58.34%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
-1.69%+3.49%+29.35%+55.18%+40.33%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cerus Corporation stock logo
CERS
Cerus
2.25
Hold$4.0055.34% Upside
Neogen Corporation stock logo
NEOG
Neogen
2.17
Hold$10.6718.32% Upside
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
1.50
Reduce$14.8836.16% Upside
STAAR Surgical Company stock logo
STAA
STAAR Surgical
2.00
Hold$19.93-24.77% Downside

Current Analyst Ratings Breakdown

Latest CERS, NEOG, STAA, and QDEL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/7/2026
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
Reiterated RatingNeutral$12.00
5/7/2026
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
DowngradeBuyHold$35.00 ➝ $12.50
5/6/2026
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
Lower Price TargetNeutral$30.00 ➝ $13.00
5/1/2026
Cerus Corporation stock logo
CERS
Cerus
UpgradeNeutralBuy$4.00
4/30/2026
Cerus Corporation stock logo
CERS
Cerus
UpgradeStrong SellHold
4/22/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
DowngradeSell (D-)Sell (E+)
4/21/2026
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
Reiterated RatingSell (E+)
4/10/2026
Neogen Corporation stock logo
NEOG
Neogen
Reiterated RatingSell (D-)
4/10/2026
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
Lower Price TargetNeutral$30.00 ➝ $17.00
4/9/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
Boost Price TargetNeutral$21.00 ➝ $26.00
4/9/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
UpgradeHoldBuy$22.00 ➝ $27.00
(Data available from 5/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cerus Corporation stock logo
CERS
Cerus
$206.13M2.50N/AN/A$0.34 per share7.57
Neogen Corporation stock logo
NEOG
Neogen
$894.66M2.19$5.67 per share1.59$9.54 per share0.94
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
$2.73B0.27$18.84 per share0.58$27.19 per share0.40
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$239.44M5.51N/AN/A$6.92 per share3.83
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cerus Corporation stock logo
CERS
Cerus
-$15.63M-$0.05N/A85.83N/A-4.41%-15.18%-4.38%N/A
Neogen Corporation stock logo
NEOG
Neogen
-$1.09B-$2.80N/A40.983.99-69.93%2.35%1.46%N/A
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
-$1.13B-$17.82N/A4.59N/A-45.57%4.25%1.56%N/A
STAAR Surgical Company stock logo
STAA
STAAR Surgical
-$80.45M-$1.63N/A120.41N/A-33.60%-10.03%-7.70%5/13/2026 (Confirmed)

Latest CERS, NEOG, STAA, and QDEL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2026Q1 2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$0.13N/AN/AN/A$78.72 millionN/A
5/5/2026Q1 2026
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
$0.37-$0.04-$0.41-$1.35$665.23 million$619.80 million
4/30/2026Q1 2026
Cerus Corporation stock logo
CERS
Cerus
-$0.03-$0.01+$0.02-$0.01$55.68 million$59.89 million
4/9/2026Q3 2026
Neogen Corporation stock logo
NEOG
Neogen
$0.04$0.09+$0.05-$0.08$204.62 million$211.20 million
3/3/2026Q4 2025
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$0.14-$0.37-$0.51-$0.37$75.54 million$57.80 million
3/2/2026Q4 2025
Cerus Corporation stock logo
CERS
Cerus
-$0.01-$0.01N/A-$0.01$59.31 million$64.58 million
2/11/2026Q4 2025
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
$0.43$0.46+$0.03-$1.92$699.80 million$723.60 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Cerus Corporation stock logo
CERS
Cerus
N/AN/AN/AN/AN/A
Neogen Corporation stock logo
NEOG
Neogen
N/AN/AN/AN/AN/A
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
N/AN/AN/AN/AN/A
STAAR Surgical Company stock logo
STAA
STAAR Surgical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cerus Corporation stock logo
CERS
Cerus
0.47
1.63
1.06
Neogen Corporation stock logo
NEOG
Neogen
0.38
3.92
2.84
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
1.33
1.43
0.90
STAAR Surgical Company stock logo
STAA
STAAR Surgical
N/A
4.55
3.74

Institutional Ownership

CompanyInstitutional Ownership
Cerus Corporation stock logo
CERS
Cerus
78.37%
Neogen Corporation stock logo
NEOG
Neogen
96.73%
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
99.00%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
96.70%

Insider Ownership

CompanyInsider Ownership
Cerus Corporation stock logo
CERS
Cerus
5.60%
Neogen Corporation stock logo
NEOG
Neogen
0.55%
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
0.79%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
0.59%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cerus Corporation stock logo
CERS
Cerus
290200.37 million189.15 millionOptionable
Neogen Corporation stock logo
NEOG
Neogen
2,110217.67 million216.48 millionOptionable
QuidelOrtho Corporation stock logo
QDEL
QuidelOrtho
6,50068.10 million67.56 millionOptionable
STAAR Surgical Company stock logo
STAA
STAAR Surgical
1,21149.79 million49.49 millionOptionable

Recent News About These Companies

2 Small-Cap Stocks Worth Your Attention and 1 We Avoid
Staar Surgical (STAA) Gets a Hold from Wedbush
Stock Movers: Intel, Meta, Staar Surgical

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cerus stock logo

Cerus NASDAQ:CERS

$2.58 -0.04 (-1.34%)
As of 11:28 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was incorporated in 1991 and is headquartered in Concord, California.

Neogen stock logo

Neogen NASDAQ:NEOG

$9.02 -0.24 (-2.54%)
As of 11:28 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

QuidelOrtho stock logo

QuidelOrtho NASDAQ:QDEL

$10.92 +0.16 (+1.44%)
As of 11:28 AM Eastern
This is a fair market value price provided by Massive. Learn more.

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.

STAAR Surgical stock logo

STAAR Surgical NASDAQ:STAA

$26.49 -0.79 (-2.90%)
As of 11:28 AM Eastern
This is a fair market value price provided by Massive. Learn more.

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.